August 1, 2014

IgG4-related disease (IgG4-RD) and its pathogenesis-Crosstalk between Innate and Acquired immunity

  1. Mitsuhiro Kawano4)
+Author Affiliations
  1. 1Division of Hematology and Immunology, Department of Internal Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 920-0293, JAPAN
  2. 2Department of Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto 606-8501
  3. 3Department of Hematology and Immunology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China
  4. 4Division of Rheumatology, Department of Internal Medicine, and Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan
  1. * Corresponding author: Hisanori Umehara Contact email: umehara606@gmail.comDepartment of Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kawahara-cho 54 Shougoin, Sakyo-ku, Kyoto 606-8501, Japan, Tel: +81-75-751-4379, FAX: +81-75-751-4338
  2. ** Present address: Department of Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto 606-8501
  • Received October 26, 2013.

Abstract

IgG4-related disease (IgG4-RD) is a novel clinical entity proposed in Japan in the 21th century and is attracting strong attention over the world. The characteristic manifestations of IgG4-RD are elevated serum IgG4 concentration and tumefaction by IgG4-positive plasma cells. Although the clinical manifestations in various organs have been established, the pathogenesis of IgG4-RD is still unknown. Recently, many reports in aberrant acquired immunity such as Th2-diminated immune responses have been published. However, many questions still remain, including questions about the pathogenesis of IgG4-RD and the roles of IgG4. In this review, we discuss the pathogenesis of IgG4-RD by focusing on the crosstalk between innate and acquired immunity.

Key words

This Article

  1. Int. Immunol.doi: 10.1093/intimm/dxu074

No comments:

Post a Comment